Investigating the Incidence of Tuberculosis during the COVID-19 Pandemic and Comparing it with One Year before the Pandemic in Hamadan City

Document Type : Original Article

Authors

1 Infectious Diseases Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.

2 3. School of Health, Hamadan University of Medical Sciences, Hamadan, Iran

3 School of Health, Hamadan University of Medical Sciences, Hamadan, Iran.

4 Tuberculosis Reference Laboratory, Deputy of Health, Hamadan University of Medical Sciences, Hamadan, Iran.

5 Department of Microbiology, Faculty of Veterinary Sciences, Ilam University, Ilam, Iran.

10.32592/JSMJ.23.1.19

Abstract

Background and Objectives The combination of tuberculosis and COVID-19 will have catastrophic effects on public health. Therefore, this study investigated the incidence of tuberculosis in the population of Hamedan City after the outbreak of COVID-19 and compared its results with one year before the pandemic. Subjects and Methods In this cross-sectional study, the data were obtained from the tuberculosis reference laboratory and tuberculosis registration station of Hamedan Health Center, and data analysis was done using Excel. Results Out of the 35 sputum samples sent before the outbreak of COVID-19, 21 (60%) were smear-positive, and 14 (66.66%) were reported as positive-culture samples. The annual incidence of pulmonary tuberculosis in Hamadan City was calculated to be about 3.6 per 100,000 population. On the other hand, one year after the outbreak of COVID-19, 11 samples were collected, of which 10 (90.9%) were smear-positive and 9 (81.81%) were positive-culture samples. The annual incidence of pulmonary tuberculosis in Hamadan City was calculated to be about 1.63 per 100,000 population. Conclusion It seems that the COVID-19 pandemic, with its impact on the diagnostic programs of the care system of Hamedan City, has led to a decrease in the diagnosis of new cases of pulmonary tuberculosis compared to the periods before the pandemic.

Keywords

Main Subjects

References

[1] Farazi AA, Jabbari Almasi M, Soufian M. The effect of intencity of sputum smear positive pulmonary tuberculosis patients on treatment response. Med Coun Islamic Rep J. 2011;29:150-6.
[2] Maher D, Chaulet P, Spinaci S, Harries A. Treatment of tuberculosis: guidelines for national programmes. Treatment of tuberculosis: guidelines for national programmes. Second edition. 1997(Ed. 2):1-77.
[3] Talay F, Kumbetli S, Altin S. Factors associated with treatment success for tuberculosis patients: a single center's experience in Turkey. Japanese journal of infectious diseases. 2008 Jan 28;61(1):25-30. [] [PMID]
[4] Palomino JC. Nonconventional and new methods in the diagnosis of tuberculosis: feasibility and applicability in the field. European Respiratory Journal. 2005 Aug 1;26(2):339-50. [10.1183/09031936.05.00050305] [PMID]
[5] Wang Q, Yu C. The role of masks and respirator protection against SARS-CoV-2. Infection Control & Hospital Epidemiology. 2020 Jun;41(6):746-7. [10.1017/ice.2020.83][PMID]
[6] Yang Y, Peng F, Wang R, Guan K, Jiang T, Xu G, Sun J, Chang C. The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. Journal of autoimmunity. 2020 May 1;109:102434. [10.1016/j.jaut.2020.102434][PMID]
[7] Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Yu T. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The lancet. 2020 Feb 15;395(10223):507-13. [10.1016/S0140-6736(20)30211-7][PMID]
[8] Hasani H, Mardi S, Shakerian S, Taherzadeh-Ghahfarokhi N, Mardi P. The novel coronavirus disease (COVID-19): a PRISMA systematic review and meta-analysis of clinical and paraclinical characteristics. BioMed research international. 2020 Aug 17;2020:1-6. [10.1155/2020/3149020][PMID]
[9] World Health Organization. WHO information note: COVID-19: considerations for tuberculosis (TB) care, 5 May 2021. World Health Organization; 2021.
[10] Ministry of Health & Medical Education (MOHME). coronavirus epidemic in Iran. Available from: http://ird.behdasht.gov.ir/
page/home.
[11] Chopra KK, Arora VK, Singh S. COVID 19 and tuberculosis. The Indian journal of tuberculosis. 2020 Apr;67(2):149. [10.1016/j. ijtb.2020.06.001][PMID]
[12] Khurana AK, Aggarwal D. The (in) significance of TB and COVID-19 co-infection. European Respiratory Journal. 2020 Aug 1;56(2). [10.1183/13993003.02105-2020][PMID]
[13] Sarınoğlu RC, Sili U, Eryuksel E, Yildizeli SO, Cimsit C, Yagci AK. Tuberculosis and COVID-19: An overlapping situation during pandemic. The Journal of Infection in Developing Countries. 2020 Jul 31;14(07):721-5. [10.3855/jidc.13152][PMID]
[14] Saunders MJ, Evans CA. COVID-19, tuberculosis and poverty: preventing a perfect storm. European Respiratory Journal. 2020 Jul 1;56(1). [10.1183/13993003.01348-2020][PMID]
[15] Tadolini M, Codecasa LR, García-García JM, Blanc FX, Borisov S, Alffenaar JW, Andréjak C, Bachez P, Bart PA, Belilovski E, Cardoso-Landivar J. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. European Respiratory Journal.
2020 Jul 1;56(1). [10.1183/13993003.01398-2020][PMID]
[16] Gao Y, Liu M, Chen Y, Shi S, Geng J, Tian J. Association between tuberculosis and COVID‐19 severity and mortality: a rapid systematic review and meta‐analysis. Journal of medical virology. 2021 Jan;93(1):194. [10.1002/jmv.26311][PMID]
[17] Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, Li Q, Jiang C, Zhou Y, Liu S, Ye C. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. Journal of infection. 2020 Aug 1;81(2):e16-25. [10.1016/j.jinf.2020.04. 021][PMID]
[18] Visca D, Ong CW, Tiberi S, Centis R, D’ambrosio L, Chen B, Mueller J, Mueller P, Duarte R, Dalcolmo M, Sotgiu G. Tuberculosis and COVID-19 interaction: a review of biological, clinical and public health effects. Pulmonology. 2021 Mar 1;27(2):151-65. [10.1016/j.pulmoe.2020.12.012][PMID]
[19] Khazaei S, Roshanaei G, Saatchi M, Rezaeian S, Zahiri A, Bathaei SJ. The epidemiological aspects of tuberculosis in Hamadan Province during 2005–11. International journal of health policy and management. 2014 Feb;2(2):75. [10.15171/ijhpm.2014.18] [PMID]
[20] Najafi Vosogh R, Roshanaei G, Khazaei S, Safari M, Zahiri A, Bothaei J. Study of Tuberculosis epidemiology and its affected factors in Hamadan province, during the years 2007-2013. Pajouhan Scientific Journal. 2015 Dec 10;14(1):64-71.
[21] Ministry of Health and Medical Education (2022), Department of Tuberculosis and Leprosy Control-Annual Report on Tuberculosi in Iran. http://tb-lep.behdasht.gov.ir/Tb_situation_in_Iran.as.
[22] Andronikou S, Welman CJ, Kader E. The CT features of abdominal tuberculosis in children. Pediatric radiology. 2002 Feb;32:75-81. [10.1007/s00247-001-0605-3] [PMID]
[23] Alene KA, Wangdi K, Clements AC. Impact of the COVID-19 pandemic on tuberculosis control: an overview. Tropical medicine and infectious disease. 2020 Jul 24;5(3):123. [10. 3390/tropicalmed5030123] [PMID]
[24] Wang X, He W, Lei J, Liu G, Huang F, Zhao Y. Impact of COVID-19 pandemic on pre-treatment delays, detection, and clinical characteristics of tuberculosis patients in Ningxia Hui Autonomous Region, China. Frontiers in public health. 2021 May 21;9:644536. [10.3389/fpubh.2021.644536] [PMID]
[25] Di Gennaro F, Gualano G, Timelli L, Vittozzi P, Di Bari V, Libertone R, Cerva C, Pinnarelli L, Nisii C, Ianniello S, Mosti S. Increase in tuberculosis diagnostic delay during first wave of the COVID-19 pandemic: data from an Italian infectious disease referral hospital. Antibiotics. 2021 Mar 8;10(3):272. [10.3390/antibiotics10030272] [PMID]
[26] Utomo B, Chan CK, Mertaniasih NM, Soedarsono S, Fauziyah S, Sucipto TH, Aquaresta F, Eljatin DS, Adnyana IM. Comparison Epidemiology between Tuberculosis and COVID-19 in East Java Province, Indonesia: An Analysis of Regional Surveillance Data in 2020. Tropical medicine and infectious disease. 2022 May 27;7(6):83. [10.3390/tropicalmed7060083] [PMID]
[27] Coronel Teixeira R, Aguirre S, Pérez Bejarano D. Thinking about tuberculosis in times of COVID‐19. Journal of Internal Medicine. 2021 Apr 1;289(4). [10.1111/joim.13192] [PMID]
[28] Shariq M, Sheikh JA, Quadir N, Sharma N, Hasnain SE, Ehtesham NZ. COVID-19 and tuberculosis: the double whammy of respiratory pathogens. European Respiratory Review. 2022 Jun 30;31(164). [10.1183/16000617.0264-2021] [PMID]
Jundishapur Scientific Medical Journal
Volume 23, Issue 1 - Serial Number 148
March and April 2024
Pages 19-31

Files

History

  • Receive Date: 09 February 2024
  • Revise Date: 26 February 2024
  • Accept Date: 09 March 2024

Share

How to cite

Statistics